title: Updates in the management of medullary thyroid cancer.
authors.affiliation: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Mimi I
authors.initials: MI
authors.lastname: Hu
mesh_terms: D018278:Carcinoma, Neuroendocrine; D000075202:Contraindications; D006801:Humans; D009377:Multiple Endocrine Neoplasia / Q000145:classification; D009154:Mutation / Q000235:genetics; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use; D012106:Research / Q000639:trends; D013577:Syndrome; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D051096:Proto-Oncogene Proteins c-ret; C452423:vandetanib